This review discusses the epidemiology, transmission, and clinical presentation of COVID-19 with a focus on its pathogenesis and the possible use of liposomal GSH as an adjunctive treatment to the current treatment modalities in COVID-19 patients
Thrombocytopenia can be induced by a host of drugs, including those that suppress the synthesis of bone marrow cells, such as hydroxycarbamide and interferon alfa-2b (IntronA)
Good practices include detox support, hydration, gut health, and focus on keeping down inflammation
The article will be updated following the July 2026 FDA Pharmacy Compounding Advisory Committee vote
Research in rodent models suggests that BPC-157 can exert a stabilizing or normalizing effect on the serotonergic system and dopaminergic pathways
Use until goal weight achieved, then maintain or taper off